These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9565530)

  • 21. Parkin and Parkinson's: more than homonymy?
    Corti O; Brice A
    Ann Neurol; 2001 Sep; 50(3):283-5. PubMed ID: 11558783
    [No Abstract]   [Full Text] [Related]  

  • 22. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular pathogenesis of familial Parkinson's disease].
    Kitada T; Mizuno Y
    Nihon Rinsho; 2000 Oct; 58(10):2016-21. PubMed ID: 11068440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights into the role of mitochondrial dysfunction and protein aggregation in Parkinson's disease.
    Xie W; Wan OW; Chung KK
    Biochim Biophys Acta; 2010 Nov; 1802(11):935-41. PubMed ID: 20674742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteome analysis of mesencephalic tissues: evidence for Parkinson's disease.
    Basso M; Giraudo S; Lopiano L; Bergamasco B; Bosticco E; Cinquepalmi A; Fasano M
    Neurol Sci; 2003 Oct; 24(3):155-6. PubMed ID: 14598063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association studies of Parkinson's disease and parkin polymorphisms.
    Klein C; Schumacher K; Jacobs H; Hagenah J; Kis B; Garrels J; Schwinger E; Ozelius L; Pramstaller P; Vieregge P; Kramer PL
    Ann Neurol; 2000 Jul; 48(1):126-7. PubMed ID: 10894229
    [No Abstract]   [Full Text] [Related]  

  • 27. Bioinformatic analysis for the identification of key candidate genes and pathways in the substantia nigra in Parkinson's disease.
    Liu H; Huang Y; Li J
    J Integr Neurosci; 2018; 17(3-4):619-631. PubMed ID: 30010140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Genetics of Parkinson's disease].
    García de Yébenes J
    Neurologia; 2001 Jan; 16(1):1-6. PubMed ID: 11234656
    [No Abstract]   [Full Text] [Related]  

  • 29. Overview of the genetics of parkinsonism.
    Gasser T
    Adv Neurol; 2003; 91():143-52. PubMed ID: 12442673
    [No Abstract]   [Full Text] [Related]  

  • 30. Spectrum of phenotypes and genotypes in Parkinson's disease.
    Riess O; Krüger R; Schulz JB
    J Neurol; 2002 Oct; 249 Suppl 3():III/15-20. PubMed ID: 12522566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Two cases of sporadic juvenile Parkinson's disease caused by homozygous deletion of Parkin gene].
    Ujike H; Yamamoto M; Yamaguchi K; Kanzaki A; Takagi M; Kuroda S
    No To Shinkei; 1999 Dec; 51(12):1061-4. PubMed ID: 10654303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry.
    Pyatigorskaya N; Sharman M; Corvol JC; Valabregue R; Yahia-Cherif L; Poupon F; Cormier-Dequaire F; Siebner H; Klebe S; Vidailhet M; Brice A; Lehéricy S
    Mov Disord; 2015 Jul; 30(8):1077-84. PubMed ID: 26011561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model.
    Klein RL; Dayton RD; Henderson KM; Petrucelli L
    Neurosci Lett; 2006 Jun; 401(1-2):130-5. PubMed ID: 16554120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers.
    Pramstaller PP; Schlossmacher MG; Jacques TS; Scaravilli F; Eskelson C; Pepivani I; Hedrich K; Adel S; Gonzales-McNeal M; Hilker R; Kramer PL; Klein C
    Ann Neurol; 2005 Sep; 58(3):411-22. PubMed ID: 16130111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinson's disease: a broken nosology.
    Hardy J; Lees AJ
    Mov Disord; 2005 Aug; 20 Suppl 12():S2-4. PubMed ID: 16092073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation mechanisms of the E3 ubiquitin ligase parkin.
    Panicker N; Dawson VL; Dawson TM
    Biochem J; 2017 Aug; 474(18):3075-3086. PubMed ID: 28860335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of penetration therapy with scalp electroacupuncture on gene expressions of nerve growth factors in substantia nigra of rats with Parkinson's disease].
    Qi XJ; Wang S
    Zhongguo Zhen Jiu; 2011 May; 31(5):435-40. PubMed ID: 21692295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The genetics of Parkinson syndrome].
    Klein C
    Praxis (Bern 1994); 2001 Jun; 90(23):1015-23. PubMed ID: 11447721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear localization of the 20S proteasome subunit in Parkinson's disease.
    Nakamura A; Kitami T; Mori H; Mizuno Y; Hattori N
    Neurosci Lett; 2006 Oct; 406(1-2):43-8. PubMed ID: 16911859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
    Orr CF; Rowe DB; Mizuno Y; Mori H; Halliday GM
    Brain; 2005 Nov; 128(Pt 11):2665-74. PubMed ID: 16219675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.